Industrial Park Insights | Taicang Biomedical Industrial Park

Industrial Park Insights | Taicang Biomedical Industrial Park

On November 27, 2020, at a signing ceremony in Shaxi, MyBioGate, Jiangsu Industrial Technology Research Institute, Taicang Innovation Investment Development, and Taicang Biomedical Industrial Park officially signed a contract to form the joint venture company TomoWave...
Overview of global pharmaceutical transactions in April

Overview of global pharmaceutical transactions in April

According to research from MyBioGate, in April, the global pharmaceutical industry reached at least 23 transactions, mainly mergers and acquisitions and licensing. M&A transactions mainly occurred between non-Chinese pharmaceutical companies. Two M&As were...
Largest Biomedical IPO of 2020: RemeGen

Largest Biomedical IPO of 2020: RemeGen

New drug approval: Telitacicept On March 12, the State Food and Drug Administration in China issued an announcement, authorizing conditional approval for RemeGen’s therapeutic biological product for injection, Telitacicept. The drug is an innovative drug TACl-Fc...